|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/7/24 Adage Capital Partners GP, L.L.C. SC 13G/A 1:98K 9 Meters Biopharma, Inc. Schulte Roth & Z… LLP/FA
9/8/23 Nasdaq Stock Market LLC 25-NSE© 2:4K 9 Meters Biopharma, Inc.
7/21/23 Sensenig Bethany 144 1:5K 9 Meters Biopharma, Inc. UBS Fin’l Svcs In… Gp/FA
7/19/23 Sirgo Mark A 144 1:13K 9 Meters Biopharma, Inc. Fidelity Brokera… LLC/FA
7/18/23 9 Meters Biopharma, Inc. 8-K:1,2,3,5 7/17/23 12:227K Command Financial
6/16/23 9 Meters Biopharma, Inc. 8-K:3 6/12/23 11:196K
5/30/23 9 Meters Biopharma, Inc. 8-K:5,9 5/26/23 13:425K
5/22/23 9 Meters Biopharma, Inc. 8-K:8 5/19/23 11:200K
5/19/23 9 Meters Biopharma, Inc. PRE 14A 5/19/23 1:1M
5/19/23 9 Meters Biopharma, Inc. 8-K:1,2,9 5/18/23 12:260K
5/15/23 9 Meters Biopharma, Inc. 10-Q 3/31/23 58:6.3M
5/15/23 9 Meters Biopharma, Inc. 8-K:2,9 5/15/23 12:379K
4/28/23 9 Meters Biopharma, Inc. 10-K/A 12/31/22 12:763K
4/27/23 9 Meters Biopharma, Inc. 8-K:1,2,9 4/26/23 12:289K
4/21/23 Sensenig Bethany 144 1:5K 9 Meters Biopharma, Inc. UBS Fin’l Svcs In… Gp/FA
4/21/23 Sensenig Bethany 4 Officer² 1:5K 9 Meters Biopharma, Inc. 9 Meters Biopharma, Inc.
4/6/23 9 Meters Biopharma, Inc. 8-K:1,3 3/31/23 10:162K
4/5/23 9 Meters Biopharma, Inc. 8-K:8,9 4/5/23 12:174K Command Financial
3/31/23 Sirgo Mark A 4 Director² 1:5K 9 Meters Biopharma, Inc. Wyrick Robbins Y… LLP/FA
3/31/23 Rice Yehuda Michael 4 Director² 1:5K 9 Meters Biopharma, Inc. Wyrick Robbins Y… LLP/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 10-Q | Quarterly Report — Form 10-Q. | | 25-NSE | Notice by a Securities Exchange of the Removal from Listing and Registration of Matured, Redeemed or Retired Securities — Form 25. | | 144 | Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }. | | PRE 14A | Preliminary Proxy Statement — Schedule 14A. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | © | This Filing was a Confirming copy. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|